Medable's platform has been deployed in Phase II and Phase III studies across oncology, CNS, respiratory, and rare disease indications, with a notable November 2024 partnership announced for deployment across an eight-EU-member-state oncology Phase III program
Possible mild side effects: flushing, headache, injection site irritation, transient hunger
It has directed sellers and suppliers to stop selling these products immediately, and said that it will not hesitate to take stern enforcement actions against anyone who sells and supplies products found to be adulterated with banned substances or potent ingredients
Compared to other organs, the brain has reduced levels of catalase and glutathione peroxidase activity, impairing its ability to neutralize H 2 O 2 and other electrophilic compounds [175, 176]